Supporting these preclinical results, a tumor tissue biopsy from a patient with metastatic prostate cancer post dordaviprone treatment, showed tumor infiltration of granzyme B+ NK cells.34 Additionally, prostate cancer patients showed increased levels of NK cells in the peripheral blood up to 3 days after dordaviprone treatment.74 Here, GZMB is linked to neoplasm.